Illinois Dispensary Rollout: From 55 Stores in 2020 to 170+ and Growing

Illinois's recreational cannabis market opened on New Year's Day 2020 with exactly 55 licensed retail dispensaries. All 55 were converted medical cannabis centers — existing medical dispensaries that received dual-use (medical + recreational) licenses under the Cannabis Regulation and Tax Act that Governor Pritzker signed in June 2019. No new businesses opened that day. The only retailers selling recreational cannabis were the same organizations that had been selling medical cannabis to card-carrying patients for years.

The immediate consequence was predictable: overwhelming demand met severely constrained supply. Lines at Chicago-area dispensaries ran three to five hours on opening weekend. Products sold out before noon on January 1 at multiple locations. Prices, already elevated by the initial license fee costs and the regulatory compliance overhead that the CRTA imposed, did not face any downward pressure from competition — there was none to be found.

Medical patients found themselves competing for the same product inventory as recreational buyers at their existing dispensaries. The CRTA required dispensaries to reserve inventory for medical patients, but the practical implementation was chaotic in the first weeks. Patient advocates criticized the rollout structure as having prioritized the political symbolism of January 1 launch over the operational reality of serving both patient and recreational demand from 55 locations across a state of 12.7 million people.

The CRTA had anticipated issuing new retail licenses beyond the 55 converted medical operators. The law authorized 75 conditional adult-use dispensary licenses in the first license allocation round, and more in subsequent rounds. The Illinois Department of Financial and Professional Regulation (IDFPR) developed a lottery-based system for awarding those licenses, with significant scoring advantages for social equity applicants — defined as individuals from communities disproportionately affected by cannabis prohibition.

The lottery process became the subject of extended litigation. Multiple applicants who did not win licenses sued the state arguing that the lottery scoring criteria were unconstitutional or applied inconsistently. Illinois courts issued injunctions that suspended the issuance of licenses for extended periods — effectively freezing new market entry for much of 2020, all of 2021, and into 2022. A market that was already supply-constrained from day one stayed constrained for two additional years because the legal pathway to new licenses was blocked.

The Illinois Supreme Court ultimately resolved the key legal challenge in 2022 in favor of the lottery structure, clearing the way for the IDFPR to begin actually issuing conditional licenses to the winners of the earlier lottery rounds. Many lottery winners had been waiting over two years to know whether their license would materialize. The subsequent buildout process — securing locations, completing construction, passing inspections, obtaining a final operating license — added further months beyond the conditional award.

New licensed dispensaries began opening in meaningful volume starting in 2022, accelerating through 2023. The Illinois dispensary count — which had stagnated at 55 plus a handful of newly issued medical-only locations — grew to over 100 stores statewide by end of 2022, over 130 by end of 2023, and past 150 by mid-2024. As of mid-2026, Illinois has over 170 licensed recreational retail locations, with more in the buildout pipeline.

The Chicago market was one of the first to feel the new competition. The city's northwest side — Logan Square, Avondale, the broader River North and Near North corridors — saw multiple new operators open in 2022 and 2023. The clustering effect that had defined the medical-era market (one dispensary serving a large geographic catchment) began to give way to something closer to actual retail competition. Ascend Logan Square IL, Ivy Hall Logan Square IL, MOCA Chicago Logan Square IL, and BLOC Kedzie Chicago IL are all products of this expansion wave — operators who won lottery licenses and eventually completed buildouts and opened.

Suburban Cook County and the collar counties also saw significant new openings. Mission Norridge IL, Curaleaf IL Justice, Sunnyside Elmwood Park IL, and Sunnyside Buffalo Grove IL all opened or significantly expanded their recreational operations during this period. Will County (Joliet) and Lake County (Highwood) received new licensed operators. The geographic distribution of Illinois cannabis retail began to look more like a mature market and less like an emergency allocation system.

Social equity was the political and moral heart of the CRTA. Illinois's law included the strongest social equity provisions of any state cannabis legalization at the time: priority licensing for individuals from Disproportionately Impacted Areas (DIA), grant programs using cannabis tax revenue to fund social equity businesses, and requirements for existing large operators to partner with or support equity applicants.

The implementation fell significantly short of the promise. The two-plus years of litigation that froze license issuance disproportionately harmed social equity applicants, who typically had less capital to weather a multi-year wait than well-funded corporate applicants. Many equity applicants who won lottery positions were unable to complete buildout financing without certainty that their license would actually be issued. Some sold or transferred their license rights to better-capitalized operators, which critics argued effectively converted the equity program's gains to conventional market participants.

By 2024 and 2025, more social equity licenses were reaching actual operation, and the Illinois Cannabis Business Development Fund had disbursed some grant funding to qualifying operators. The equity dispensaries now operating include some of the newer Chicago and suburban stores. But the gap between the equity program's ambition and its first-five-years implementation remains a legitimate criticism of Illinois's rollout, and it is part of why the license expansion that was supposed to happen in 2020–2021 ended up delayed until 2022–2024.

Illinois's recreational cannabis market in mid-2026 is materially different from the 55-store bottleneck of 2020. With over 170 licensed retail locations and a competitive wholesale market that has pushed prices downward across most categories, the acute shortage period is over. Dispensary lines on opening day in 2020 were measured in hours; today's Chicago dispensaries serve customers without unusual waits.

The structural constraints that remain are primarily tax-driven. The CRTA's potency-tiered excise, Chicago's city surcharge, and the baseline state sales tax collectively produce an out-of-pocket burden that keeps Illinois prices significantly above Michigan's despite comparable or lower pre-tax menu prices in some categories. This is a legislative choice, not a market failure — Illinois's tax design was deliberate, and changing it would require statutory action.

Where the market goes from here: more licenses are expected to be issued under subsequent rounds of the equity and standard application processes. The licensed cultivation base continues to grow, which applies downward pressure on wholesale costs. Prices will likely continue declining, particularly in flower and edibles — the categories with the most competitive supply. Concentrates and vapes face a steeper path to price normalization due to both manufacturing barriers and the 25% excise layer. CloudedDeals tracks all 25 Illinois dispensaries daily to capture wherever prices are falling today.